Hyperfine, Inc. Reports Record Quarterly Revenue and Raises FY 2024 Revenue Guidance
August 08, 2024 16:05 ET
|
Hyperfine, Inc.
─ Reports $3.6M in Q2 2024 Revenue; 50% Gross Margin─ Raises FY 2024 Revenue Guidance to $13-16M GUILFORD, Conn., Aug. 08, 2024 (GLOBE NEWSWIRE) -- Hyperfine, Inc. (Nasdaq: HYPR), the...
Hyperfine, Inc. Reports First Quarter 2024 Financial Results
May 13, 2024 16:05 ET
|
Hyperfine, Inc.
GUILFORD, Conn., May 13, 2024 (GLOBE NEWSWIRE) -- Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared portable...
Hyperfine, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results
March 21, 2024 16:05 ET
|
Hyperfine, Inc.
GUILFORD, Conn., March 21, 2024 (GLOBE NEWSWIRE) -- Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared portable...
Hyperfine, Inc. Reports Third Quarter 2023 Financial Results
November 09, 2023 16:05 ET
|
Hyperfine, Inc.
GUILFORD, Conn., Nov. 09, 2023 (GLOBE NEWSWIRE) -- Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking medical device company that has redefined brain imaging with the world’s first FDA-cleared,...
Hyperfine, Inc. Reports Second Quarter 2023 Financial Results
August 14, 2023 16:05 ET
|
Hyperfine, Inc.
GUILFORD, Conn., Aug. 14, 2023 (GLOBE NEWSWIRE) -- Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking medical device company that created the Swoop® system, the world's first FDA-cleared portable,...
Hyperfine, Inc. Reports First Quarter 2023 Financial Results
May 11, 2023 16:05 ET
|
Hyperfine, Inc.
GUILFORD, Conn., May 11, 2023 (GLOBE NEWSWIRE) -- Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking medical device company that created the Swoop® system, the world's first FDA-cleared portable,...
Hyperfine, Inc. to Announce First Quarter Financial Results on May 11, 2023
April 20, 2023 16:05 ET
|
Hyperfine, Inc.
GUILFORD, Conn., April 20, 2023 (GLOBE NEWSWIRE) -- Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking medical device company that created the Swoop® system, the world's first FDA-cleared portable...
Hyperfine, Inc. Reports Fourth Quarter and Full Year 2022 Financial Results
March 21, 2023 16:05 ET
|
Hyperfine, Inc.
GUILFORD, Conn., March 21, 2023 (GLOBE NEWSWIRE) -- Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking medical device company that created the Swoop® system, the world's first FDA-cleared portable...
Hyperfine, Inc. to Announce Fourth Quarter and Full Year 2022 Financial Results on March 21, 2023
March 06, 2023 08:55 ET
|
Hyperfine, Inc.
GUILFORD, Conn., March 06, 2023 (GLOBE NEWSWIRE) -- Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking medical device company that created the Swoop® system, the world's first FDA-cleared portable...
Hyperfine, Inc. Receives FDA Clearance for Updated Software to Further Improve Diffusion-Weighted Imaging
February 28, 2023 08:55 ET
|
Hyperfine, Inc.
GUILFORD, Conn., Feb. 28, 2023 (GLOBE NEWSWIRE) -- Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking medical device company that created the Swoop® system, the world’s first FDA-cleared portable...